Ubiquinol vs ubiquinone: the reduced and oxidised forms
Ubiquinol is coenzyme Q10 with its quinone ring reduced; ubiquinone is the same molecule with the ring oxidised. The difference is two hydrogen atoms and two electrons: ubiquinol is C59H92O4, CAS 992-78-9, and ubiquinone is C59H90O4, CAS 303-98-0. They are a redox pair, not a salt and a free acid, so the choice is not a conversion at the balance; it is a choice about oxidation state, stability and the label.
Ubiquinol and ubiquinone differ by two hydrogen atoms and one redox step, not by a salt; the reduced form is the harder one to keep reduced.
One redox step, two materials
The quinone ring is the switch. Ubiquinone carries a quinone; ubiquinol carries the same ring as a hydroquinone, with two hydroxyl groups where the quinone had carbonyls. The isoprenoid tail is unchanged. That is why the two forms have almost the same molecular weight and the same fat solubility, and why a mass-based conversion between them is trivial compared with the analytical problem of telling them apart.
| Property | Ubiquinol | Ubiquinone |
|---|---|---|
| Redox state | Reduced (hydroquinone) | Oxidised (quinone) |
| CAS number | 992-78-9 | 303-98-0 |
| Formula | C59H92O4 | C59H90O4 |
| Molecular weight | 865.36 | 863.34 |
| Appearance | White to pale yellow powder or oil | Yellow to orange-yellow powder |
| Catalog assay | ≥95.0% by HPLC | 98.0–101.0% by HPLC |
| Counter-form limit | Ubiquinone ≤2.0% | Ubiquinol bounded by the related-substance method |
The two certificates do not read the same way
Ubiquinol is specified at ≥95.0% by HPLC with ubiquinone ≤2.0%; ubiquinone is specified at 98.0–101.0% with a melting point of 48–52 °C. The ubiquinol figure needs its oxidation partner beside it, because the reduced form is defined partly by how much has not oxidised.
The mass difference is only 2.02 g/mol, about 0.23%. A 100 mg label of ubiquinol and a 100 mg label of ubiquinone describe almost the same mass; what differs is the redox state. A “CoQ10” assay that does not name the form and the wavelength can be read as either.
The USP monograph for ubiquinol sets 96.0–102.0% on the anhydrous basis, while the catalog floor here is 95.0%. The two gates are close but not identical; a 95.5% result on the anhydrous basis clears the catalog number and misses the monograph. A “total CoQ10” result after an oxidation step measures the sum and destroys the information about the form.
Why storage moves the reduced form
Ubiquinol oxidises to ubiquinone in air, and light, heat and trace metal ions accelerate the reaction. The oxidised form is the more stable one, which is the practical asymmetry: ubiquinone can be stored with less protection, while ubiquinol has to be packed and handled to keep it reduced.
The rate depends on the surface, the oxygen available and the temperature. A powder has a large surface; an oil dissolves oxygen; a warm hold speeds both. A softgel fill protects the material from air after filling but adds a heat step before it. The pack and the headspace are part of the specification, not a logistics detail.
This is why the word “ubiquinol” alone is not a specification. The form has to be still reduced at release and through shelf life, and that is a measured result. How the pack is tested is set out under stability.
The label has to name the form
A label that carries only the stem “CoQ10” does not say which form is inside. US practice has generally read “coenzyme Q10” as ubiquinone, while ubiquinol is a separate dietary ingredient with its own new-dietary-ingredient notification; a Supplement Facts panel should name the form the finished product contains. In the EU, the novel-food status and the permitted form have to be checked for the exact material and the member state; a supplier statement about “CoQ10” does not automatically cover the reduced form.
In Great Britain, the FSA register of novel food authorisations is the reference; Northern Ireland follows the EU list. The destination address decides which applies. The label, the specification and the market file should all name the same form, and the buyer's regulatory team confirms the route; this page does not.
When each form fits
Choose ubiquinol when the label calls for the reduced form and the dosage form can protect it: a softgel fill, an oil blend, or a sealed powder pack with a controlled headspace. Choose ubiquinone when the label calls for the oxidised form, when the process and the pack cannot exclude oxygen, or when the market file covers only that form.
Do not choose by a conversion factor. The molecular weights differ by 0.23%, so the mass is not the issue; the oxidation state, the analytical method, the stability data and the label are. A switch in either direction needs a new specification, a new certificate, a stability check for the pack and a label review.
Ubiquinone is described on the coenzyme Q10 product page; the ubiquinol catalog is on the ubiquinol product page; the release tests are on the COA page; the analytical methods are collected under methods; the release workflow is on the quality page.
Specification lines for each form
- “Name the redox form, the CAS number and the formula.”
- “Ubiquinol: assay ≥95.0% by HPLC, ubiquinone ≤2.0%, with the basis and the wavelength.”
- “Ubiquinone: assay 98.0–101.0% by HPLC, melting point 48–52 °C.”
- “State the pack and the storage condition; the reduced form needs the oxygen and light barrier.”
- “Match the label name to the form the market file covers.”
No disease-related claim is made on this page. The specification describes the powder; whether it can be sold is a separate question for the destination.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation